| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |